LRRK2 and Parkinson disease: Further, the mutation in MAP kinase (MAPK) domain G2019S is mainly known due to late-onset LRRK2-associated PD and raises Vmax for kinase activity, whereas the Roc domain-specific Y1699C and R1441C/G/H mutations lower GTPase activity [94].